HUVEC and HDMEC were seeded in 96-well plates and exposed 24 h later to different doses of CYT D. After 24 and 96 h (HUVEC) or 24 and 72 h (HDMEC) of treatment, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 0.5 mg/ml; Sigma-Aldrich) was added in the culture medium in a ratio of 1:10. After 4 h of incubation with the MTT solution, formazan crystals, derived by the degradation of MTT into the mitochondria of living cells, were dissolved in ethanol/DMSO (1:1), and absorbance was measured at 550 nm using Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific). Viability was calculated by comparing the absorbance of each treatment to the untreated (-) sample at 24 h. The experiments were repeated five times in triplicate.
For samples deriving from the RWV, the beads were collected from the vessels, washed with phosphate-buffered saline, trypsinized, stained with trypan blue solution (0.4%), and counted using Luna Automated Cell Counter (Logos Biosystems, Anyang, South Korea). The experiment was performed three times in triplicate.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.